PUMA BIOTECHNOLOGY INC (PBYI) Stock Price, Quote & AI Analysis
Live PBYI stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for PUMA BIOTECHNOLOGY INC.
TradeVae provides AI-driven analysis and real-time market intelligence for PUMA BIOTECHNOLOGY INC (PBYI), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
PUMA BIOTECHNOLOGY INC's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
PUMA BIOTECHNOLOGY INC Overview
Company information
Company Overview
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
PUMA BIOTECHNOLOGY INC Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...